Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder
In Vivo · 2024
DOI: 10.21873/invivo.13573 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Daisuke Gotoh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, Kashihara, Japan. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Urinary Bladder, Overactive. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nara Medical University, Kashihara, Japan.
- Department of Urology, Nara Medical University, Kashihara, Japan torimoto@naramed-u.ac.jp.
Zitieren
APA
Gotoh, D., Torimoto, K., Takamatsu, N., Onishi, K., Morizawa, Y., Hori, S., Nakai, Y., Miyake, M., & Fujimoto, K. (2024). Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder. In Vivo. https://doi.org/10.21873/invivo.13573
Vancouver
Gotoh D, Torimoto K, Takamatsu N, Onishi K, Morizawa Y, Hori S, et al. Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder. In Vivo. 2024. doi:10.21873/invivo.13573
BibTeX
@article{Gotoh2024,
author = {Gotoh, Daisuke and Torimoto, Kazumasa and Takamatsu, Norimi and Onishi, Kenta and Morizawa, Yosuke and Hori, Shunta and Nakai, Yasushi and Miyake, Makito and Fujimoto, Kiyohide},
title = {Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13573}
}
EUVIMED